Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin

Masayuki Hiramatsu, Toshitaka Nabeshima, Hiroaki Fukaya, Hiroshi Furukawa

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We investigate the effects of thiorphan, a specific inhibitor of enkephalinase A and bestatin, a specific inhibitor of aminopeptidase, on the stereotyped behaviors induced by phencyclidine (PCP) in cannulated rats. The PCP-induced turning was significantly potentiated when thiorphan (50 μg) and bestatin (50 μg) were injected simultaneously into the rat lateral ventricle. The increase of PCP-induced turning was completely antagonized by the pretreatment with naloxone. Thiorphan (50 μg) or bestatin (50 μg) alone failed to potentiate PCP-induced turning. Thiorphan and/or bestatin did not affect significantly the PCP-induced head weaving and back-pedalling except that thiorphan (50 μg) potentiated the PCP-induced head weaving 15-18 min after the PCP injection. The combination of thiorphan and bestatin alone did not induce any behavioral change. These results suggest that thiorphan and bestatin produce an increase of endogenous enkephalins and that as a result, PCP-induced turning may be enhanced.

Original languageEnglish
Pages (from-to)69-74
Number of pages6
JournalEuropean Journal of Pharmacology
Volume120
Issue number1
DOIs
Publication statusPublished - 14-01-1986
Externally publishedYes

Fingerprint

Thiorphan
Stereotyped Behavior
Phencyclidine
Head
Neprilysin
Aminopeptidases
Enkephalins
Lateral Ventricles
Naloxone
ubenimex
Foot
Injections

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Hiramatsu, Masayuki ; Nabeshima, Toshitaka ; Fukaya, Hiroaki ; Furukawa, Hiroshi. / Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin. In: European Journal of Pharmacology. 1986 ; Vol. 120, No. 1. pp. 69-74.
@article{c2e135ae33b949b7aa7a4bcd223f25b3,
title = "Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin",
abstract = "We investigate the effects of thiorphan, a specific inhibitor of enkephalinase A and bestatin, a specific inhibitor of aminopeptidase, on the stereotyped behaviors induced by phencyclidine (PCP) in cannulated rats. The PCP-induced turning was significantly potentiated when thiorphan (50 μg) and bestatin (50 μg) were injected simultaneously into the rat lateral ventricle. The increase of PCP-induced turning was completely antagonized by the pretreatment with naloxone. Thiorphan (50 μg) or bestatin (50 μg) alone failed to potentiate PCP-induced turning. Thiorphan and/or bestatin did not affect significantly the PCP-induced head weaving and back-pedalling except that thiorphan (50 μg) potentiated the PCP-induced head weaving 15-18 min after the PCP injection. The combination of thiorphan and bestatin alone did not induce any behavioral change. These results suggest that thiorphan and bestatin produce an increase of endogenous enkephalins and that as a result, PCP-induced turning may be enhanced.",
author = "Masayuki Hiramatsu and Toshitaka Nabeshima and Hiroaki Fukaya and Hiroshi Furukawa",
year = "1986",
month = "1",
day = "14",
doi = "10.1016/0014-2999(86)90641-2",
language = "English",
volume = "120",
pages = "69--74",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin. / Hiramatsu, Masayuki; Nabeshima, Toshitaka; Fukaya, Hiroaki; Furukawa, Hiroshi.

In: European Journal of Pharmacology, Vol. 120, No. 1, 14.01.1986, p. 69-74.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin

AU - Hiramatsu, Masayuki

AU - Nabeshima, Toshitaka

AU - Fukaya, Hiroaki

AU - Furukawa, Hiroshi

PY - 1986/1/14

Y1 - 1986/1/14

N2 - We investigate the effects of thiorphan, a specific inhibitor of enkephalinase A and bestatin, a specific inhibitor of aminopeptidase, on the stereotyped behaviors induced by phencyclidine (PCP) in cannulated rats. The PCP-induced turning was significantly potentiated when thiorphan (50 μg) and bestatin (50 μg) were injected simultaneously into the rat lateral ventricle. The increase of PCP-induced turning was completely antagonized by the pretreatment with naloxone. Thiorphan (50 μg) or bestatin (50 μg) alone failed to potentiate PCP-induced turning. Thiorphan and/or bestatin did not affect significantly the PCP-induced head weaving and back-pedalling except that thiorphan (50 μg) potentiated the PCP-induced head weaving 15-18 min after the PCP injection. The combination of thiorphan and bestatin alone did not induce any behavioral change. These results suggest that thiorphan and bestatin produce an increase of endogenous enkephalins and that as a result, PCP-induced turning may be enhanced.

AB - We investigate the effects of thiorphan, a specific inhibitor of enkephalinase A and bestatin, a specific inhibitor of aminopeptidase, on the stereotyped behaviors induced by phencyclidine (PCP) in cannulated rats. The PCP-induced turning was significantly potentiated when thiorphan (50 μg) and bestatin (50 μg) were injected simultaneously into the rat lateral ventricle. The increase of PCP-induced turning was completely antagonized by the pretreatment with naloxone. Thiorphan (50 μg) or bestatin (50 μg) alone failed to potentiate PCP-induced turning. Thiorphan and/or bestatin did not affect significantly the PCP-induced head weaving and back-pedalling except that thiorphan (50 μg) potentiated the PCP-induced head weaving 15-18 min after the PCP injection. The combination of thiorphan and bestatin alone did not induce any behavioral change. These results suggest that thiorphan and bestatin produce an increase of endogenous enkephalins and that as a result, PCP-induced turning may be enhanced.

UR - http://www.scopus.com/inward/record.url?scp=0022649210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022649210&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(86)90641-2

DO - 10.1016/0014-2999(86)90641-2

M3 - Article

C2 - 3456306

AN - SCOPUS:0022649210

VL - 120

SP - 69

EP - 74

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -